In the United States, the Institute of Society, Ethics and the Life
Sciences—later the Hastings Center—was founded in 1969, and Georgetown's
Kennedy Institute of Ethics followed in 1971. Philosophers, theologians,
lawyers, historians, social scientists, clinicians, and public members
increasingly joined debates once treated as internal medical affairs.
“Bioethics” came to cover not only professional conduct but research,
reproduction, death and dying, genetics, public policy, and the life
sciences.
In 1979, Tom Beauchamp and James Childress's
Principles of Biomedical Ethics
systematized an influential vocabulary of autonomy, beneficence,
non-maleficence, and justice. These principles can clarify conflicting
reasons, but they are neither the only ethical framework nor timeless
facts discovered in ancient texts. Feminist, disability,
communitarian, religious, antiracist, public-health, and global-health
approaches have criticized accounts that imagine an isolated chooser
while overlooking dependency, care, inaccessible institutions, family and
community relations, or unequal distributions of risk and power.
The shift from professional authority to public accountability was also
incomplete. Patients do not all seek the same role; capacity can be
decision-specific and change over time; interpreters and accessible
communication affect whether choice is real; and a nominal freedom to
choose means little where only one option is affordable or available.
Consent remains necessary in many settings, but it is not a substitute
for competent care, sound evidence, privacy, fair access, or protection
from exploitation.